-
Association of Endothelial Dysfunction With Chronic Marijuana Smoking and THC-Edible Use JAMA Cardiol. (IF 14.8) Pub Date : 2025-05-28
Leila Mohammadi, Mina Navabzadeh, Nerea Jiménez-Téllez, Daniel D. Han, Emma Reagan, Jordan Naughton, Lylybell Y. Zhou, Rahul Almeida, Leslie M. Castaneda, Shadi A. Abdelaal, Kathryn S. Park, Keith Uyemura, Christian P. Cheung, Mehmet Nur Onder, Natasha Goyal, Poonam Rao, Judith Hellman, Jing Cheng, Joseph C. Wu, Gregory M. Marcus, Matthew L. SpringerImportanceRecreational and medicinal cannabis legalization has led to increased cannabis use. To understand the consequences for vascular health, we initiated the CANnabis: Does It Damage Endothelium (CANDIDE) study.ObjectiveTo investigate whether cannabis use is associated with vascular endothelial dysfunction.Design, Setting, and ParticipantsIn this cross-sectional study, sex- and age- matched healthy
-
Left Ventricular Noncompaction Cardiomyopathy JAMA Cardiol. (IF 14.8) Pub Date : 2025-05-21
Muhammad Adnan Zaman, Sidra Kalsoom, Lou MastrineThis case report describes an echocardiography-based diagnosis of left ventricular noncompaction cardiomyopathy in a male patient in his 40s who presented with sudden-onset dyspnea.
-
Finerenone in Heart Failure With Improved Ejection Fraction JAMA Cardiol. (IF 14.8) Pub Date : 2025-05-21
Maria A. Pabon, Orly Vardeny, Muthiah Vaduganathan, Akshay S. Desai, Brian L. Claggett, Ian J. Kulac, Pardeep S. Jhund, Carolyn S. P. Lam, Michele Senni, Sanjiv J. Shah, Adriaan A. Voors, Faiez Zannad, Bertram Pitt, Clara I. Saldarriaga, Mark C. Petrie, Béla Merkely, Maria Borentain, Katharina Mueller, Prabhakar Viswanathan, Flaviana Amarante, Alanna Morris, John J. V. McMurray, Scott D. SolomonImportancePatients with chronic heart failure (HF) and left ventricular ejection fraction (LVEF) less than 40% who experience LVEF improvement to 40% or higher (HFimpEF) may still face residual risks.ObjectiveTo assess the clinical profiles, risk, and treatment response to finerenone in participants with HFimpEF.Design, Setting, and ParticipantsA total of 6001 patients with HE, LVEF of 40% or higher
-
Regulatory Approval vs Guideline Endorsement of Novel BP-Lowering Treatments JAMA Cardiol. (IF 14.8) Pub Date : 2025-05-21
Ritika Revoori, John W. McEvoy, Cian P. McCarthyThis Viewpoint describes the benefits and barriers of conducting cardiovascular disease outcome trials to provide evidence of effectiveness of novel blood pressure (BP)–lowering therapies in reducing hypertension.
-
Polygenic Prediction of Peripheral Artery Disease and Major Adverse Limb Events JAMA Cardiol. (IF 14.8) Pub Date : 2025-05-21
Alyssa M. Flores, Yunfeng Ruan, Anika Misra, So Mi Jemma Cho, Margaret S. Selvaraj, Tiffany R. Bellomo, Tetsushi Nakao, Kenneth Rosenfield, Matthew Eagleton, Whitney Hornsby, Aniruddh P. Patel, Pradeep NatarajanImportancePeripheral artery disease (PAD) is a heritable atherosclerotic condition associated with functional decline and high risk for limb loss. With growing knowledge of the genetic basis for PAD and related risk factors, there is potential opportunity to identify individuals at high risk using polygenic risk scores (PRSs).ObjectiveTo develop a novel integrated, multiancestry polygenic score for
-
The Limitations and Risks Associated With Semaglutide Treatment-Reply. JAMA Cardiol. (IF 14.8) Pub Date : 2025-05-14
Ivy Shi,Sadiya S Khan,Dhruv S Kazi -
Reimbursement Transformation Is Essential for Digital Health Adoption in Cardiovascular Care JAMA Cardiol. (IF 14.8) Pub Date : 2025-05-14
John Connolly, Seth S. Martin, Karen E. Joynt Maddox, Thomas M. MaddoxThis Viewpoint describes innovations in digital health approaches to cardiovascular care delivery and discusses the need for reimbursement reform to support adoption.
-
Reimbursement for AI-Balancing Innovation, Adoption, and the Medicare Trust Fund. JAMA Cardiol. (IF 14.8) Pub Date : 2025-05-14
Lee A Fleisher -
Early Childhood Food Insecurity and Cardiovascular Health in Young Adulthood JAMA Cardiol. (IF 14.8) Pub Date : 2025-05-14
Emily L. Lam, Abigail M. Gauen, Namratha R. Kandula, Daniel A. Notterman, Noreen Goldman, Donald M. Lloyd-Jones, Norrina B. Allen, Nilay S. ShahImportanceFood insecurity is a social risk factor that may be associated with cardiovascular health across the life course.ObjectiveTo evaluate the association of food insecurity in early childhood with cardiovascular health (CVH) in young adulthood and whether associations are modified by participation during childhood in the Supplemental Nutrition Assistance Program (SNAP).Design, Setting, and ParticipantsThe
-
The Limitations and Risks Associated With Semaglutide Treatment. JAMA Cardiol. (IF 14.8) Pub Date : 2025-05-14
Vanita Rahman -
Chest Tube–Induced Right Ventricular Failure After Cardiac Surgery JAMA Cardiol. (IF 14.8) Pub Date : 2025-05-07
Stefan R. van Dinter, Wilson W. L. Li, Nabil SaoutiThis case report discusses a diagnosis of right ventricular heart failure secondary to chest tube placement during resternotomy in a male patient aged 73 years.
-
Epidemiological and Translational Study of Calprotectin and Atherosclerotic Cardiovascular Disease JAMA Cardiol. (IF 14.8) Pub Date : 2025-05-07
Yu Zuo, Somanathapura K. NaveenKumar, Sherwin Navaz, Wenying Liang, Kavya Sugur, Katarina Kmetova, Colby R. Ayers, Lyndsay Kluge, Emily Chong, Amil M. Shah, Anand Rohatgi, Jarett D. Berry, Jason S. Knight, James A. de LemosImportanceInnate immunity, particularly neutrophil activation, plays a crucial role in the pathogenesis of atherosclerotic cardiovascular disease (ASCVD). The potential of calprotectin, a biomarker of neutrophil activation, as a mechanistically informed biomarker for ASCVD in an ethnically diverse population requires further investigation.ObjectiveTo examine the prospective association between circulating
-
Surgical Treatment of Hypertrophic Cardiomyopathy in Ukraine During War JAMA Cardiol. (IF 14.8) Pub Date : 2025-05-07
Barry J. Maron, Ethan J. Rowin, Martin S. MaronThis essay describes a cardiac surgeon’s experience performing surgical septal myectomy for symptomatic obstructive hypertrophic cardiomyopathy during wartime in Ukraine as related during recent interviews with the authors.
-
Intracoronary Structural-Molecular Imaging for Multitargeted Characterization of High-Risk Plaque JAMA Cardiol. (IF 14.8) Pub Date : 2025-05-07
Sunwon Kim, Hyeong Soo Nam, Dong Oh Kang, Jeongmoo Han, Hyokee Kim, Joon Woo Song, Eun Jin Park, Ryeong Hyun Kim, Hyun Jung Kim, Jin Hyuk Kim, Sunki Lee, Young Su Kim, Pyoungjae Park, Man-Jong Baik, Hongki Yoo, Jin Won KimImportanceFluorescence lifetime imaging (FLIm) is a molecular imaging technique used to visualize the biochemical composition of atherosclerosis. Novel dual-modal imaging using optical coherence tomography (OCT)-FLIm has the potential to provide both microstructural and biocompositional information on coronary plaques; however, it needs validation for clinical application.ObjectiveTo investigate the
-
Effect of Alirocumab in Atherosclerotic Plaques-Reply. JAMA Cardiol. (IF 14.8) Pub Date : 2025-04-30
Flavio Giuseppe Biccirè,Lorenz Räber -
Cardiomyopathy-Associated Gene Variants in Atrial Fibrillation JAMA Cardiol. (IF 14.8) Pub Date : 2025-04-30
Leonoor F. J. M. Wijdeveld, Ezimamaka Ajufo, Saketh P. Challa, Joel T. Rämö, Xin Wang, Shinwan Kany, Jennifer L. Halford, Lu-Chen Weng, Seung Hoan Choi, Krishna G. Aragam, J. Peter van Tintelen, Bianca J. J. M. Brundel, Sean J. Jurgens, Patrick T. EllinorImportancePatients with atrial fibrillation (AF), a common morbid arrhythmia, are more likely to carry rare genetic variants associated with inherited cardiomyopathies. Prior studies on rare pathogenic variants in AF relied on small, hospital referral populations, and knowledge on clinical outcomes remains limited.ObjectiveTo evaluate the prevalence and prognostic implications of cardiomyopathy-associated
-
Effect of Alirocumab in Atherosclerotic Plaques. JAMA Cardiol. (IF 14.8) Pub Date : 2025-04-30
Kyriakos Dimitriadis,Nikolaos Pyrpyris,Konstantinos Tsioufis -
OCT vs Angiography for Guidance of Percutaneous Coronary Intervention of Calcified Lesions JAMA Cardiol. (IF 14.8) Pub Date : 2025-04-30
Nicolas Amabile, Gregoire Rangé, Quentin Landolff, Erwan Bressollette, Nicolas Meneveau, Benoit Lattuca, Sebastien Levesque, Ziad Boueri, Julien Adjedj, Frederic Casassus, Ayoub Belfekih, Aurelie Veugeois, Géraud Souteyrand, Benjamin HontonImportanceThe use of intravascular imaging for calcified plaque characterization and preparation has been advocated over conventional methods to improve percutaneous coronary intervention (PCI) outcomes, but this approach has never been evaluated.ObjectiveTo determine if optical coherence tomography (OCT) is superior to angiography for calcified lesions PCI guidance.Design, Setting, and ParticipantsThe
-
OCT and Calcium-You Cannot Treat What You Cannot See. JAMA Cardiol. (IF 14.8) Pub Date : 2025-04-30
Marc-André d'Entremont,Sanjit S Jolly -
AI-Assisted Point-of-Care Ultrasound Networks—Considerations for Rural Health Care Delivery JAMA Cardiol. (IF 14.8) Pub Date : 2025-04-30
Amanda Chang, Jordan B. Strom, Kan LiuThis Viewpoint explores how artificial intelligence–assisted point-of-care ultrasound could be used to create coordinated networks of care to improve health care access and delivery in rural communities.
-
Financial Insecurity and Cardiometabolic Health-A Matter of Survival. JAMA Cardiol. (IF 14.8) Pub Date : 2025-04-23
Megan McLaughlin,Michelle A Albert -
Cumulative Life’s Essential 8 Scores and Cardiovascular Disease Risk JAMA Cardiol. (IF 14.8) Pub Date : 2025-04-23
James Walker, Daniel Won, James Guo, Jamal S. Rana, Norrina B. Allen, Hongyan Ning, Donald M. Lloyd-JonesImportanceMost literature on the association between cardiovascular health (CVH) and incident cardiovascular disease (CVD) and mortality has relied on single midlife measurements. Understanding how cumulative CVH over time influences later-life CVD and mortality may aid early prevention.ObjectiveTo determine whether cumulative CVH, as measured by the American Heart Association Life’s Essential 8 (LE8)
-
Cuffless Blood Pressure Measurement Devices—International Perspectives on Accuracy and Clinical Use JAMA Cardiol. (IF 14.8) Pub Date : 2025-04-23
Eugene Yang, Aletta E. Schutte, George Stergiou, Fernando Stuardo Wyss, Yvonne Commodore-Mensah, Augustine Odili, Ian Kronish, Hae-Young Lee, Daichi ShimboImportanceHypertension is a primary modifiable risk factor for cardiovascular death and disability. Accurate blood pressure (BP) measurement is essential for the diagnosis and treatment of hypertension. Conventional BP measurement with cuff devices is recommended but difficult for patients to perform due to inconvenience, discomfort, and challenges with appropriate cuff sizing and measurement protocols
-
Emergency Department–Based Education and mHealth Empowerment Intervention for Hypertension JAMA Cardiol. (IF 14.8) Pub Date : 2025-04-23
Heather Prendergast, Spyros Kitsiou, Renee Petzel Gimbar, Sally Freels, Anissa Sanders, Martha Daviglus, Pavitra Kotini-Shah, Barry Carter, Marina Del Rios, Sara Heinert, Shaveta KhoslaImportanceHypertension is a leading risk factor for cardiovascular diseases and is often undiagnosed. Emergency department (ED) visits serve as critical access points within health care and present a unique opportunity for hypertension screening and intervention.ObjectiveTo evaluate the effectiveness of an Education and mHealth Empowerment (E2) intervention compared with usual care in reducing systolic
-
Temporary Mechanical Cardiac Support Outcomes and Cardiogenic Shock-Reply. JAMA Cardiol. (IF 14.8) Pub Date : 2025-04-16
Jacob Eifer Møller,Nanna Louise Junker Udesen,Christian Hassager -
Temporary Mechanical Cardiac Support Outcomes and Cardiogenic Shock. JAMA Cardiol. (IF 14.8) Pub Date : 2025-04-16
Federico Pappalardo,Nicoletta D'Ettore,Andrea Montisci -
Artificial Intelligence–Enabled Prediction of Heart Failure Risk From Single-Lead Electrocardiograms JAMA Cardiol. (IF 14.8) Pub Date : 2025-04-16
Lovedeep S. Dhingra, Arya Aminorroaya, Aline F. Pedroso, Akshay Khunte, Veer Sangha, Daniel McIntyre, Clara K. Chow, Folkert W. Asselbergs, Luisa C. C. Brant, Sandhi M. Barreto, Antonio Luiz P. Ribeiro, Harlan M. Krumholz, Evangelos K. Oikonomou, Rohan KheraImportanceDespite the availability of disease-modifying therapies, scalable strategies for heart failure (HF) risk stratification remain elusive. Portable devices capable of recording single-lead electrocardiograms (ECGs) may enable large-scale community-based risk assessment.ObjectiveTo evaluate whether an artificial intelligence (AI) algorithm can predict HF risk from noisy single-lead ECGs.Design
-
Automated Deep Learning Phenotyping of Tricuspid Regurgitation in Echocardiography JAMA Cardiol. (IF 14.8) Pub Date : 2025-04-16
Amey Vrudhula, Milos Vukadinovic, Christiane Haeffele, Alan C. Kwan, Daniel Berman, David Liang, Robert Siegel, Susan Cheng, David OuyangImportanceAccurate assessment of tricuspid regurgitation (TR) is necessary for identification and risk stratification.ObjectiveTo design a deep learning computer vision workflow for identifying color Doppler echocardiogram videos and characterizing TR severity.Design, Setting, and ParticipantsAn automated deep learning workflow was developed using 47 312 studies (2 079 898 videos) from Cedars-Sinai
-
Periconceptional Glucagon-Like Peptide-1 Receptor Agonist Use and Discontinuation JAMA Cardiol. (IF 14.8) Pub Date : 2025-04-16
Sadiya S. Khan, William A. Grobman, Dhruv S. KaziThis Viewpoint describes the need for more studies on the best timing for dicontinuation of glucagon-like peptide-1 receptor agonists before pregnancy.
-
Progressive Kidney Dysfunction After Left Atrial Appendage Closure. JAMA Cardiol. (IF 14.8) Pub Date : 2025-05-01
Shuaishuai Yuan,Chao Tao,Peijun Li -
Self-Administered Etripamil and Emergency Department Visits in Supraventricular Tachycardia JAMA Cardiol. (IF 14.8) Pub Date : 2025-04-09
Sean D. Pokorney, A. John Camm, Paul Dorian, James E. Ip, Bruce S. Stambler, David B. Bharucha, Jonathan P. PicciniThis secondary analysis of a randomized clinical trial describes the use of emergency care after self-administration of etripamil by patients experiencing paroxysmal supraventricular tachycardia episodes at home.
-
Accountable Care Organization Participation and Cardiovascular Care Quality JAMA Cardiol. (IF 14.8) Pub Date : 2025-04-04
Erica S. Spatz, D. August Oddleifson, Jehanzeb Kayani, Kensey L. Gosch, Philip G. Jones, Rushabh H. Doshi, Thomas M. Maddox, Nihar R. DesaiImportanceThe Medicare Shared Savings Program (MSSP) was introduced in 2012 to improve care quality and lower costs to Medicare. Under this program, accountable care organizations (ACOs) assumed responsibility for costs and care quality for a group of Medicare beneficiaries.ObjectiveTo compare changes in quality measures for patients at outpatient cardiology practices before and after their participation
-
Hypertensive Disorders of Pregnancy and Long-Term Risk of Dilated Cardiomyopathy JAMA Cardiol. (IF 14.8) Pub Date : 2025-04-04
Upasana Tayal, Constantinos Kallis, Georgie M. Massen, Nora Rossberg, Emily L. Graul, Jennifer K. QuintImportanceThe impact of hypertensive disorders of pregnancy on developing dilated cardiomyopathy is unknown.ObjectiveTo determine whether hypertensive disorders of pregnancy are associated with long-term risk of dilated cardiomyopathy.Design, Setting, and ParticipantsThis population-based cohort study performed in England used the following linked electronic health records databases: Clinical Practice
-
Adverse Pregnancy Outcomes and N-Terminal Pro-Brain Natriuretic Peptide Levels 2 to 7 Years After Delivery: The nuMoM2b Heart Health Study. JAMA Cardiol. (IF 14.8) Pub Date : 2025-05-01
Priya M Freaney,Xiaoning Huang,Lucia C Petito,William A Grobman,Janet Catov,Alisse Hauspurg,C Noel Bairey Merz,Natalie Bello,Jin Kyung Kim,Abbi Lane,David M Haas,Lisa D Levine,Rebecca B McNeil,Eliza Miller,George Saade,Lauren Theilen,Lynn M Yee,Jasmina Varagic,Brian Mercer,Uma Reddy,Donald M Lloyd-Jones,Philip Greenland,Sadiya S Khan, -
Rural America-Expanding the Lens of Health Disparities: Endorsing the Need for Health Equity Research. JAMA Cardiol. (IF 14.8) Pub Date : 2025-03-31
Sadiya S Khan,Clyde W Yancy -
Mining the Electronic Medical Record for Hypertension Treatment-Hope or Hype? JAMA Cardiol. (IF 14.8) Pub Date : 2025-03-31
Sadiya S Khan -
Cardiovascular Health Among Rural and Urban US Adults—Healthcare, Lifestyle, and Social Factors JAMA Cardiol. (IF 14.8) Pub Date : 2025-03-31
Michael Liu, Lucas X. Marinacci, Karen E. Joynt Maddox, Rishi K. WadheraImportanceImproving cardiovascular health in rural areas is a national priority in the US. However, little is known about the current state of rural cardiovascular health and the underlying drivers of any rural-urban disparities.ObjectiveTo compare rates of cardiometabolic risk factors and cardiovascular diseases between rural and urban US adults and to evaluate the extent to which health care access
-
Leveraging Preexisting Cardiovascular Data to Improve the Detection and Treatment of Hypertension JAMA Cardiol. (IF 14.8) Pub Date : 2025-03-31
Adam N. Berman, Michael K. Hidrue, Curtis Ginder, Linnea Shirkey, Japneet Kwatra, Anna C. O’Kelly, Sean P. Murphy, Jennifer M. Searl Como, Danielle Daly, Yee-Ping Sun, William T. Curry, Marcela G. del Carmen, Ron Blankstein, John A. Dodson, David A. Morrow, Benjamin M. Scirica, Niteesh K. Choudhry, James L. Januzzi, Jason H. WasfyImportanceHypertension is often underrecognized, leading to preventable morbidity and mortality. Tailored data systems combined with care augmented by trained nonphysicians have the potential to improve cardiovascular care.ObjectiveTo determine whether previously collected cardiovascular imaging data could be harnessed to improve the detection and treatment of hypertension through a system-level intervention
-
Mode of Death in Patients With Heart Failure With Mildly Reduced or Preserved Ejection Fraction JAMA Cardiol. (IF 14.8) Pub Date : 2025-03-30
Akshay S. Desai, Pardeep S. Jhund, Muthiah Vaduganathan, Brian L. Claggett, Jonathan W. Cunningham, Maria A. Pabon, Carolyn S. P. Lam, Michele Senni, Sanjiv Shah, Adriaan A. Voors, Faiez Zannad, Bertram Pitt, Flaviana Amarante, James Lay-Flurrie, Markus F. Scheerer, Andrea Lage, John J. V. McMurray, Scott D. SolomonImportanceThe mode of death in patients with heart failure with mildly reduced ejection fraction (HFmrEF) or heart failure with preserved ejection fraction (HFpEF) remains poorly understood and may vary by EF.ObjectiveTo evaluate the mode of death according to EF and the treatment effect of finerenone on cause-specific mortality in patients with HFmrEF/HFpEF.Design, Setting, and ParticipantsThis was
-
Finerenone and Atrial Fibrillation in Heart Failure JAMA Cardiol. (IF 14.8) Pub Date : 2025-03-29
Shingo Matsumoto, Alasdair D. Henderson, Pardeep S. Jhund, Johann Bauersachs, Ovidiu Chioncel, Brian L. Claggett, Josep Comin-Colet, Akshay S. Desai, Gerasimos Filippatos, Carolyn S. P. Lam, Bertram Pitt, Markus Florian Scheerer, James Lay-Flurrie, Flaviana Amarante, Meike Brinker, Morten Schou, Michele Senni, Sanjiv J. Shah, Adriaan A. Voors, Faiez Zannad, Shelley Zieroth, Muthiah Vaduganathan, ScottImportanceHeart failure (HF) with mildly reduced or preserved ejection fraction and atrial fibrillation (AF) are closely intertwined.ObjectiveTo examine the efficacy and safety of the nonsteroidal mineralocorticoid receptor antagonist finerenone in patients with HF with mildly reduced or preserved ejection fraction according to the absence or presence of AF and the type of AF (paroxysmal vs persistent
-
Aortic Valve Intervention for Asymptomatic Aortic Stenosis. JAMA Cardiol. (IF 14.8) Pub Date : 2025-03-26
Rick A Nishimura,Patrick T O'Gara,Robert O Bonow -
Asundexian or Apixaban in Patients With Atrial Fibrillation According to Prior Oral Anticoagulant Use JAMA Cardiol. (IF 14.8) Pub Date : 2025-03-26
John H. Alexander, Elizabeth J. Lydon, Jonathan P. Piccini, Thomas Viethen, Jonas Oldgren, Shaun G. Goodman, Jan Steffel, Andrea M. Russo, Isabelle C. van Gelder, Keith C. Ferdinand, Renato D. Lopes, Hardi Mundl, Bela Benczur, Juan José Gómez-Doblas, Michael Glikson, Assen Goudev, Erik L. Grove, Sigrun Halvorsen, Tuomas Kiviniemi, Anne-Céline Martin, Roopinder K. Sandhu, Dragos Vinereanu, Frank W.ImportanceIn patients with atrial fibrillation (AF), oral anticoagulants (OACs) reduce the risk of stroke.ObjectiveTo investigate if patients with less prior OAC exposure respond differently to a new OAC than patients with more OAC exposure.Design, Setting, and ParticipantsIn this prespecified exploratory subgroup analysis of the Oral Factor 11a Inhibitor Asundexian as Novel Antithrombotic–Atrial Fibrillation
-
Encouraging Pharmacist Referrals for Evidence-Based Statin Initiation JAMA Cardiol. (IF 14.8) Pub Date : 2025-03-26
Alexander C. Fanaroff, Qian Huang, Kayla Clark, Laurie A. Norton, Wendell E. Kellum, Dwight Eichelberger, John C. Wood, Zachary Bricker, Andrea G. Dooley Wood, Greta Kemmer, Jennifer I. Smith, Srinath Adusumalli, Mary E. Putt, Kevin G. VolppImportanceDespite statins’ benefit in preventing major adverse cardiovascular events, most patients with an indication for statin therapy are not appropriately treated. Clinicians’ limited time and lack of systematic efforts to address preventive care likely contribute to gaps in statin prescribing.ObjectiveTo determine the effect on statin prescribing of 2 interventions to refer appropriate patients
-
Peak Oxygen Uptake vs Ventilatory Efficiency. JAMA Cardiol. (IF 14.8) Pub Date : 2025-05-01
Jiawei Du,Jinghua Hou -
Peak Oxygen Uptake Vs Ventilatory Efficiency-In Reply. JAMA Cardiol. (IF 14.8) Pub Date : 2025-05-01
Matthew M Y Lee,Gregory D Lewis -
A Man in His 30s With Ponytail Coronary Artery Anomaly. JAMA Cardiol. (IF 14.8) Pub Date : 2025-05-01
Leizhi Ku,Xiaojing Ma -
Joint Associations of APOC3 and LDL-C–Lowering Variants With the Risk of Coronary Heart Disease JAMA Cardiol. (IF 14.8) Pub Date : 2025-03-19
Wenxiu Wang, Rui Li, Zimin Song, Ninghao Huang, Tao Huang, Xinwei Hua, Yi-Da TangImportanceDespite substantial progress in low-density lipoprotein cholesterol (LDL-C)–lowering strategies, residual cardiovascular risk remains. Apolipoprotein C3 (APOC3) has emerged as a novel target for lowering triglycerides. Multiple clinical trials of small-interfering RNA therapeutics targeting APOC3 are currently underway.ObjectiveTo investigate whether genetically predicted lower APOC3 is associated
-
Concomitant Mechanical Aspiration and Appendage Closure for Recalcitrant Left Atrial Appendage Thrombi JAMA Cardiol. (IF 14.8) Pub Date : 2025-03-19
Maryam Saleem, Abhishek Maan, Daniel R. Musikantow, Chi Zhang, Yury Malyshev, Marc A. Miller, Srinivas R. Dukkipati, Parasuram M. Krishnamoorthy, Martin Goldman, Prakash Krishnan, Vivek Y. ReddyImportanceIt is well appreciated that a small yet high-risk subset of patients with atrial fibrillation (AF) develops persistent left atrial appendage (LAA) thrombus despite optimal oral anticoagulation (OAC). In patients with either a heightened risk of bleeding precluding enhanced doses of OAC to dissolve the thrombus, or thromboembolism despite optimal OAC, there are limited nonsurgical options
-
FFR-Guided Percutaneous Coronary Intervention vs Coronary Artery Bypass Grafting in Patients With Diabetes. JAMA Cardiol. (IF 14.8) Pub Date : 2025-03-12
Kuniaki Takahashi,Hisao Otsuki,Frederik M Zimmermann,Victoria Y Ding,Thomas Engstrøm,Hans Gustav Hørsted Thyregod,Branko Beleslin,Svetozar Putnik,Luke Tapp,Thomas Barker,Simon Redwood,Christopher Young,G Jan-Willem Bech,Gerard J F Hoohenkerk,Bernard De Bruyne,Nico H J Pijls,William F Fearon,Importance Outcomes in patients with diabetes after fractional flow reserve (FFR)-guided percutaneous coronary intervention (PCI) using current-generation drug-eluting stents (DES) compared with coronary artery bypass grafting (CABG) are unknown. Objectives To investigate the relative treatment effect of PCI vs CABG according to diabetes status with respect to major adverse cardiac and cerebrovascular
-
Food Insecurity and Incident Cardiovascular Disease Among Black and White US Individuals, 2000-2020 JAMA Cardiol. (IF 14.8) Pub Date : 2025-03-12
Jenny Jia, Mercedes R. Carnethon, Mandy Wong, Cora E. Lewis, Pamela J. Schreiner, Namratha R. KandulaImportanceFood insecurity is associated with prevalent cardiovascular disease (CVD), but studies have been limited to cross-sectional data.ObjectivesTo study whether food insecurity is associated with incident CVD and to determine whether this association varies by sex, education, or race.Design, Setting, and ParticipantsThis prospective cohort study was conducted among US adults without preexisting
-
Exercise-Induced Dyspnea in an Older Woman With a History of Coronary Artery Disease JAMA Cardiol. (IF 14.8) Pub Date : 2025-03-12
Soundous M’Rabet, Jean-Christophe Eicher, Charles GuenanciaAn older woman with a history of coronary artery disease presents with dyspnea upon exertion. A transthoracic echocardiogram reveals severe mitral regurgitation, and an electrocardiogram reveals sinus tachycardia with left bundle branch block. What would you do next?
-
Novel Controlled Metabolic Accelerator for Obesity-Related HFpEF JAMA Cardiol. (IF 14.8) Pub Date : 2025-03-12
Ambarish Pandey, Gregory D. Lewis, Barry A. Borlaug, Sanjiv J. Shah, Andrew J. Sauer, Sheldon Litwin, Kavita Sharma, Diane K. Jorkasky, Elizabeth A. Tarka, Shaharyar M. Khan, Dalane W. KitzmanImportanceExcess body fat plays a pivotal role in the pathogenesis of heart failure with preserved ejection fraction (HFpEF). HU6 is a novel, controlled metabolic accelerator that enhances mitochondrial uncoupling resulting in increased metabolism and fat-specific weight loss.ObjectiveTo assess efficacy and safety of HU6 in reducing body weight, improving peak volume of oxygen consumption (VO2) and
-
Filling the Evidence Gaps Toward a Coronary Artery Calcium-Guided Primary Prevention Strategy. JAMA Cardiol. (IF 14.8) Pub Date : 2025-05-01
Michael J Blaha -
Valsartan and Cardiac Remodeling in Early-Stage Hypertrophic Cardiomyopathy: The VANISH Randomized Clinical Trial Cardiac Magnetic Resonance Substudy. JAMA Cardiol. (IF 14.8) Pub Date : 2025-03-05
John W Ostrominski,Brian L Claggett,Michael Jerosch-Herold,Anna Axelsson Raja,Sharlene M Day,Mark W Russell,Kenneth Zahka,Alexandre C Pereira,Steven D Colan,Anne M Murphy,Charles Canter,Richard G Bach,Matthew T Wheeler,Joseph W Rossano,Anjali T Owens,Luisa Mestroni,Matthew R G Taylor,Amit R Patel,Ivan Wilmot,Jonathan H Soslow,Jason R Becker,Neal K Lakdawala,Henning Bundgaard,Jose D Vargas,Carolyn YImportance Valsartan has been shown to attenuate phenotypic progression among individuals with early-stage sarcomeric hypertrophic cardiomyopathy (HCM). Myocardial tissue characterization by cardiac magnetic resonance (CMR) imaging may enhance mechanistic insights, but whether valsartan influences these parameters remains uncertain. Objective To evaluate the treatment effects of valsartan on myocardial
-
Finerenone for Heart Failure and Risk Estimated by the PREDICT-HFpEF Model JAMA Cardiol. (IF 14.8) Pub Date : 2025-03-05
Kirsty McDowell, Kieran F. Docherty, Ross T. Campbell, Alasdair D. Henderson, Pardeep S. Jhund, Brian L. Claggett, Akshay S. Desai, James Lay-Flurrie, Lucas Hofmeister, Andrea Scalise, Carolyn S. P. Lam, Mark C. Petrie, Morten Schou, Michele Senni, Sanjiv J. Shah, Jacob A. Udell, Faiez Zannad, Bertram Pitt, Muthiah Vaduganathan, Scott D. Solomon, John J. V. McMurrayImportancePatients with heart failure (HF) and mildly reduced ejection fraction (HFmrEF) or preserved ejection fraction (HFpEF) have a spectrum of risk, and the effect of therapies may vary by risk.ObjectivesTo validate the Prognostic Models for Mortality and Morbidity in HFpEF (PREDICT-HFpEF) in the phase 3 randomized clinical trial Finerenone Trial to Investigate Efficacy and Safety Superior to Placebo
-
Coronary Artery Calcium Testing—Too Early, Too Late, Too Often JAMA Cardiol. (IF 14.8) Pub Date : 2025-03-05
Alexander R. Zheutlin, Anuj K. Chokshi, John T. Wilkins, Neil J. StoneImportanceTraditional risk factors, enhancing factors, and risk scores help clinicians assess atherosclerotic cardiovascular disease (ASCVD) risk for primary prevention. The latest cholesterol guidelines suggest measuring coronary artery calcium (CAC) score by computed tomography (CT) in those at intermediate risk when there is uncertainty about statin initiation for primary prevention. CAC testing
-
Importance of Age and Sex in Carotid Artery Plaque Detection and Cardiovascular Disease Risk JAMA Cardiol. (IF 14.8) Pub Date : 2025-03-05
Matthew C. Tattersall, Spencer L. Hansen, Robyn L. McClelland, Claudia E. Korcarz, Kristin M. Hansen, Wendy S. Post, Michael D. Shapiro, James H. SteinImportanceCarotid artery plaque (CAP) is commonly encountered in clinical practice. Presence of CAP predicts future atherosclerotic cardiovascular disease (ASCVD) events; however, CAP prevalence increases with age, and it is unknown how age and sex affect the association of CAP presence and ASCVD risk.ObjectivesTo describe CAP prevalence by age, sex, race, and ethnicity in a multiethnic population
-
Simultaneous or Rapid Initiation of Combination Therapy for Heart Failure With Preserved Ejection Fraction JAMA Cardiol. (IF 14.8) Pub Date : 2025-03-05
Stephen J. Greene, Javed Butler, Gregg C. FonarowThis Viewpoint recommends simultaneous or rapid sequence initiation of combination therapy with 3 specific classes of medication for heart failure with mildly reduced ejection fraction or preserved ejection fraction.
-
Finerenone and Outpatient Worsening Heart Failure With Mildly Reduced or Preserved Ejection Fraction JAMA Cardiol. (IF 14.8) Pub Date : 2025-02-26
Jonathan W. Cunningham, Safia Chatur, Brian L. Claggett, Muthiah Vaduganathan, Akshay S. Desai, Pardeep S. Jhund, Guillermo Llamas Esperón, Carolyn S. P. Lam, Naoki Sato, Michele Senni, Sanjiv Shah, Adriaan Voors, Faiez Zannad, Bertram Pitt, Shelley Zieroth, Meike Brinker, Katja Rohwedder, So-Young Kim, James Lay-Flurrie, Prabhakar Viswanathan, John J. V. McMurray, Scott D. SolomonImportanceWorsening heart failure (HF) is commonly managed in the outpatient setting with adjustments in oral diuretic therapy. The effect of the nonsteroidal mineralocorticoid receptor antagonist finerenone on outpatient worsening HF events in patients with mildly reduced or preserved ejection fraction is unknown.ObjectiveTo evaluate the effect of finerenone on outpatient worsening HF events requiring
-
New Right Atrial Image After Coronary Revascularization Surgery JAMA Cardiol. (IF 14.8) Pub Date : 2025-02-26
Clara Nuevo-Gallardo, María Reyes González-Fernández, María Yuste-DomínguezThis case report describes a saphenous vein graft simulating an intracardiac structure on echocardiography of a patient after coronary revascularization surgery.